In South San Francisco, Genentech showed that recombinant DNA technology could transform medicine and create therapies once ...

The real drug development delay? Bad communication.

David Craig’s operating manual for building biotech companies in today’s market is now available in hardcover and as an ...

Biotech companies are spending billions to perfect chemical formulas, only to be tripped up by the one variable they forgot ...

Seven life sciences companies cut at least 346 jobs in Massachusetts between April and June, with some of the layoffs tied to ...

VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager ...

Psychedelic therapy developer Definium Therapeutics convinced a federal judge in Delaware on Wednesday to dismiss a lawsuit ...

By Karen Roman Imviva Biotech said it has FDA authorization for its Investigational Device Exemption application to use ...

The industry contributes $50 billion to the state GDP, and employs 130,000 people across research and manufacturing.

A French drugmaker just bet up to $1.75 billion on a cancer drug that's only been tested on 19 patients — why?

Seeking biotech investment, breakthrough innovations, or a strategic gateway to the Asia-Pacific? The answers await in Hong Kong this September.HONG KONG, July 7, 2026 /PRNewswire/ -- The 5th Hong ...

Call AI in biotech hype at your peril. There are real reasons that pharmaceutical companies are embracing this technology ...